Diabetic Pathophysiology

Type2 diabetes mellitus is characterized by a both combinations of inadequate insulin secretion by pancreatic beta cells and peripheral insulin resistance. Insulin resistance, which has been associate to proinflammatory cytokines in plasma  and elevated levels of free fatty acids, it leads to decreased glucose transport into muscle cells, elevated hepatic glucose production, and increased breakdown of fat. The major role for excess glucagon cannot be underestimated; indeed, Type2 diabetes (T2D)  is an islet paracrinopathy in which the reciprocal relationship between the insulin-secreting beta cell and the glucagon-secreting alpha cell is lost, which leads to hyperglucagonemia and hence the consequent hyperglycaemia. For type 2 diabetes mellitus (T2DM) to occur, both insulin resistance and inadequate insulin secretion must exist. Generally all overweight or obese individuals have insulin resistance, but diabetes develops only in those individuals who cannot raise insulin secretion to that level so that it can compensate for their insulin resistance. Their insulin concentrations may be high, which results in low level of glycaemia.

  • Acute pancreatitis symptoms
  • Identification of β-cell dysfunction and insulin resistance
  • Differentiation of diabetes by pathophysiology, natural history
  • Clinical features of diabetes mellitus

Related Conference of Diabetic Pathophysiology

December 9-10, 2019

12th World Congress on Endocrinologyand Metabolic Disorders

Bangkok, Thailand
December 12-13, 2019

Annual Congress on Diabetes and Endocrinology

Dubai, UAE
June 28-30 2020

diabetes management 2020

March 25-26, 2020

29th World Diabetes & Heart Congress

Tokyo, Japan
April 13-14, 2020

World congress on Endocrinology and Metabolic syndrome

Auckland, Newzealand
June 15-16, 2020

29thEuropean Diabetes Congress

Barcelona, Spain
July 06-07, 2020

Annual Congress on Diabetes, Metabolism and Obesity

Sydney, Australia
July 15-16, 2020

3rd Global Diabetes Summit

Helsinki, Finland
July 15-16, 2020

28th International Diabetes and Healthcare Conference

Helsinki, Finland
August 17-18, 2020

16th World Congress on Endocrinology & Diabetes

| Copenhagen, Denmark
August 24-25, 2020

Global Summit On Diabetes & Endocrinology

Kyoto, Japan
August 24-25, 2020

Annual Summit on Diabetes and Endocrinology

Barcelona, Spain
September 22-23, 2020

2nd Asia Pacific Endocrinology Congress

Singapore City, Singapore
September 28-29, 2020

4th Annual Congress on Diabetes, Obesity and Its Complications

Singapore City, Singapore
October 04-05, 2020

World Summit on Blood Glucose Monitoring

Beijing, China
October 07-08, 2020

International Summit on Diabetes

Barcelona, Spain
October 12-13, 2020

Global Congress on Endocrinology and Gynaecology

Sydney, Australia
October 14-15, 2020

World Congress on Endocrinology & Diabetes

Rome, Italy
October 30-31, 2020

Annual Summit on Metabolomics

Vancouver, Canada
November 09-10, 2020

International Congress and Expo on Diabetic Care

Bangkok, Thailand
November 16-17, 2020

World congress and Expo on Diabetes

Kyoto, Japan
November 16-17, 2020

2nd Asia Pacific Diabetes and Endocrinology Congress

Brisbane, Australia

Diabetic Pathophysiology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in